TPH1 and fatty liver disease: Mice depleted for TPH1 (Tph1-/-) are protected from HFD-induced obesity and related metabolic dysfunctions, showing less weight gain, lower adiposity, reduced insulin resistance, and liver steatosis compared to control mice 227.